Catalyst Wire Dossier Catalyst Wire Dossier

Wujia Yizhi Granules

· Sichuan Jishengtang Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Wujia Yizhi Granules, covering 2025-12-29 to 2025-12-29. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney) [Phase 3]

See pricing